Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial-mesenchymal transition in triple-negative breast cancer
AbstractContext Tabersonine has been investigated for its role in modulating inflammation-associated pathways in various diseases. However, its regulatory effects on triple-negative breast cancer (TNBC) have not yet been fully elucidated.Objective This study uncovers the anticancer properties of tab...
Saved in:
Main Authors: | Xi Chen (Author), Yuanliang Yan (Author), Yuanhong Liu (Author), Qiaoli Yi (Author), Zhijie Xu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells
by: Li JP, et al.
Published: (2015) -
Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells
by: Ding YH, et al.
Published: (2015) -
<i>Urtica dioica</i> Leaf Infusion Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Cisplatin Treatment
by: Guy Nafeh, et al.
Published: (2023) -
Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial–mesenchymal transition
by: Chen D, et al.
Published: (2016) -
PKMYT1 promotes epithelial-mesenchymal transition process in triple-negative breast cancer by activating notch signaling
by: Bin Li, et al.
Published: (2024)